Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03712085
Other study ID # YN2018HK03
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 15, 2019
Est. completion date December 2021

Study information

Verified date July 2019
Source Guangzhou University of Traditional Chinese Medicine
Contact Hongxia Chen, Master
Phone 020-39318381
Email chx2004@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Using random number method to categorize the selected first onset patients with stroke who meet the inclusion criteria into 3 groups.The patients were randomly divided into treatment group A(abdominal acupuncture+upper limb rehabilitation training, 22 cases), treatment group B(Sham abdominal acupuncture+upper limb rehabilitation training, 22 cases),and control group(upper limb rehabilitation training, 22 cases). SEMG and fMRI examination and related stroke rehabilitation assessment scales were evaluated before and after treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 66
Est. completion date December 2021
Est. primary completion date January 2021
Accepts healthy volunteers No
Gender All
Age group 35 Years to 75 Years
Eligibility Inclusion Criteria:

1. First onset stroke, Left hemiplegia, Right-handed,and diagnosed by brain CT or MRI;

2. Age 35 to 75 years old;

3. Course of disease 0.5 to 3 months with stable vital signs;

4. No cognitive impairment. Can understand and execute commands. MMSE score more than 7 points. ;

5. Can control the sitting balance. Brunnstrom stage of hemiplegic upper limb and hand is ? or V ,Fugl-Meyer Motor Assessment score of upper limb 20-50 point;

6. Agree to sign the informed consent;

7. Unilateral neglect.

Exclusion Criteria:

1. Recurrent stroke,subarachnoid hemorrhage, brain tumors patients;

2. Contraindication to undergo a 3T MR imaging;

3. Claustrophobia;

4. Have severe heart, hepatic or renal failure;

5. Don' t cooperate with the treatment;

6. Have participated in other clinical trails recently.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Abdominal acupuncture
Abdominal acupuncture treatment method: 1.Acupoints selection :Zhongwan,Xiawan,Shangqu,Qihai,Guanyuan,Huaroumen,Upper rheumatic and Upper rheumatic external points etc.(Acupoints selection referred to Abdominal Acupuncture Therapy written by Bo Zhiyun ,the founder of Abdominal Acupuncture. 2.Treatment Duration: 30 minutes a session, once a day, 5 times a week for 3 weeks.
Sham abdominal acupuncture
Sham abdominal acupuncture Abdominal acupuncture treatment method: 1.Acupoints selection and treatment duration are the same as abdominal acupuncture. 3.Method:Using the sham abdominal acupuncture needles were produced by DONGBANG AcuPrime Acupuncture Instrument Co., Ltd. ( U.K.)The tip of the needle was exposed to 1mm of the cannula. The acupoint skin of patients was touched gently by the tip, and the tip of needle was lifted and removed from acupoint skin after 30s. Rest for 30 seconds ,then repeated 6 times, a total time of stimulation is 6min.

Locations

Country Name City State
China Guangdong Provincial Hospital of Traditional Chinese Medicine Guangzhou Guangdong
Hong Kong The Chinese University of Hong Kong Hong Kong

Sponsors (2)

Lead Sponsor Collaborator
Guangzhou University of Traditional Chinese Medicine Chinese University of Hong Kong

Countries where clinical trial is conducted

China,  Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary The integrity of the corticospinal tract The integrity of the corticospinal tract will be tested by diffusion trnsor imaging(DTI) of craniocerebral functional magnetic resonance imaging examination using magetic angiography to measure the changes caused by neuronal activity.We will observe the shape and integrity of the corticospinal tract. Diffusion tensor imaging(DTI) will be tested before treatment and 4 weeks after treatment,twice totally.
Primary Motor function of muscles Common measures of sEMG will be tested. See the study protocol for details. SEMG will be tested before and after 4 weeks treatment,twice totally.
Secondary Wolf Motor Function Test See the study protocol for details Before treatment, 2 weeks and 4 weeks after treatment, 3 times totally.
Secondary Brunnstrom staging of upper limb movement See the study protocol for details Before treatment, 2 weeks and 4 weeks after treatment, 3 times totally.
Secondary Fugl-Meyer Motor Assessment of upper limb See the study protocol for details Before treatment, 2 weeks and 4 weeks after treatment, 3 times totally.
Secondary Modified Barthel Index,MBI See the study protocol for details Before treatment, 2 weeks and 4 weeks after treatment, 3 times totally.
See also
  Status Clinical Trial Phase
Completed NCT05131295 - Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage. Phase 3
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Completed NCT01955642 - Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke N/A
Recruiting NCT01541163 - Heart and Ischemic STrOke Relationship studY N/A
Recruiting NCT06076122 - Salicornia for Neurovascular Health Improve N/A
Not yet recruiting NCT04386525 - Omega 3 and Ischemic Stroke; Fish Oil as an Option Phase 4
Recruiting NCT06270927 - A Feasibility Study for Randomization of Code Stroke Imaging Strategies
Completed NCT02912546 - Cerebral Perfusion Associated With Postural Changes: an ASL MR Perfusion Study N/A
Completed NCT02684825 - Detection of Silent Atrial Fibrillation aFter Ischemic StrOke N/A
Completed NCT05815836 - Precision Medicine in Stroke
Recruiting NCT01673932 - Safety and Feasibility Study of Umbilical Cord Blood Mononuclear Cells Transplant to Treat Ischemic Stroke Phase 1
Recruiting NCT01556802 - Use of Minocicline in Patients With Stroke Phase 1
Completed NCT02101606 - Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke Phase 2
Completed NCT00829361 - Stroke Telemedicine for Arizona Rural Residents Trial N/A
Terminated NCT00073372 - A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II) Phase 3
Recruiting NCT04908241 - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT) N/A
Recruiting NCT04188132 - EEG Based BCI for Upper Limb Rehabilitation in Stroke N/A
Completed NCT01713491 - Pre-stroke Cognitive Status and Thrombolytic Therapy N/A
Completed NCT01443962 - The Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy N/A
Terminated NCT01059149 - Safety and Long-term Effectiveness of High Frequency Repetitive Transcranial Magnetic Stimulation of Stroke (RAICup) Phase 2